Loading organizations...
Loading organizations...
Biopharmaceutical company developing oxygen-therapeutic agents.
Sangart has raised $50.0M across 1 funding round.
Sangart has raised $50.0M in total across 1 funding round.
Sangart has raised $50.0M in total across 1 funding round.
Sangart's investors include Leucadia National Corporation.
Sangart has raised $50.0M across 1 funding round. Most recently, it raised $50.0M Series G in April 2011.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 19, 2011 | $50.0M Series G | Leucadia National Corporation |